A Phase Iii Trial In Progress Comparing Tislelizumab Plus Concurrent Chemoradiotherapy (Ccrt) With Placebo Plus Ccrt In Patients With Localized Esophageal Squamous Cell Carcinoma (Escc)

Wei-Hu Wang,Jiancheng Li,Tao Li,Kuaile Zhao,Rong Yu,Wenqing Wang,Mingqiu Chen,Long Liang, Jiyan Zou,Yidi Wang,Wei Shen, Zhe Wu,Zefen Xiao

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 0|浏览43

暂无评分

摘要

TPS475Background: In China, esophageal cancer (EC) ranks as the eigth most common cancer and the sixth most common cause of cancer related death. The predominant histological subtype of EC is ESCC....

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要